Post-stroke cognitive impairment (results of a 5-year follow-up)

Verbitskaya, S V; Parfenov, V. А.; Решетников, В. А.; Kozlov, Vasiliy; Кабаева, А. Р.

doi:10.14412/2074-2711-2018-1-37-42

Cited by 25 publications

(7 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…10 The prevalence of cognitive impairment after stroke is high worldwide, ranging from 11.6% to 68.2% in various hospital-based studies. 11 It was discovered to be 56.3% in Austria, 12 68.2% in Indonesia, 4 21% in Russia, 13 54.5% in Singapore, 14 55% in Portugal, 15 and 63% in Uganda. 16 Post-stroke cognitive impairment (PSCI) is associated with impaired activities of daily living, which may lead to increased use of health-care services, decreased capacity for independent living, and decreased functional performance.…”

Section: Introductionmentioning

confidence: 99%

Prevalence and Associated Factors of Cognitive Impairment Among Stroke Survivors at Comprehensive Specialized Hospitals in Northwest Ethiopia: Multi-Centered Cross-Sectional Study

Cherkos¹,

Jember²,

Mihret³

et al. 2023

VHRM

View full text Add to dashboard Cite

Background: Deficit in cognitive impairment is the most serious of the stroke sequelae. Post-stroke cognitive impairment is associated with impaired daily living activities and decreased capacity for independent living and functional performance. As a result, the purpose of this study was to determine the prevalence and associated factors of cognitive impairment among stroke survivors at comprehensive specialized hospitals in Ethiopia's Amhara region by 2022. Methods: A multi-centered cross-sectional study was designed at an institution. During the study period. Data was gathered by conducting structured questionnaire interviews with participants and reviewing medical charts with trained data collectors. The participants were chosen using a systematic random sampling technique. The Montreal cognitive assessment basic was used to assess cognitive impairment. Descriptive statistics, binary and multivariate logistic regression methods were used to analyze the data. The Hosmer-Lemeshow goodness-of-fit test was used to assess the fitness of the model. The AOR with a P value of 0.05 at 95% CI was reported, and variables were considered statistically significant. Results: This study enrolled 422 stroke survivors. Overall, 58.3% of stroke survivors had cognitive impairment (95% CI 53.4-63.0%). The study participants' age with AOR;), being hypertensive with AOR; 7. 52 (3.46-16.35), arriving at the hospital after 24 hours with AOR; 4.33 (1.49-12.05), less than three months after stroke with AOR; 4. 83 (3.95-12.19), dominant hemisphere lesion with AOR;) and being illiterate with AOR; were found significant factors. Conclusion:Cognitive impairment was discovered to be relatively common among stroke survivors in this study. More than half of stroke survivors who attended comprehensive specialized hospitals during the study period were found to have cognitive impairment. Age, hypertension, arriving at the hospital after 24 hours, less than three months after stroke, dominant hemisphere lesion, and illiterate educational status were all significant factors in cognitive impairment.

show abstract

Section: Introductionmentioning

confidence: 99%

Prevalence and Associated Factors of Cognitive Impairment Among Stroke Survivors at Comprehensive Specialized Hospitals in Northwest Ethiopia: Multi-Centered Cross-Sectional Study

Cherkos¹,

Jember²,

Mihret³

et al. 2023

VHRM

View full text Add to dashboard Cite

show abstract

“…В их число входят когнитивные нарушения, а также расстройства, затрагивающие эмоциональную, мотивационную и личностные сферы пациента. Важность изучения причин, патогенеза, молекулярных биомаркеров инсульта, а также разработки своевременной диагностики и коррекции нейропсихологических нарушений обусловлена их влиянием на реабилитационный прогноз, продолжительность и качество жизни пациентов, перенесших ОНМК [6,7].…”

Section: онмк -острое нарушение мозгового кровообращенияunclassified

Diagnostic of psychoemotional and cognitive impairments in acute ischemic stroke

Tynterova

2021

Physical and rehabilitation medicine, medical rehabilitation

View full text Add to dashboard Cite

Aims: to assess the severity of cognitive, psychoemotional, behavioral disorders, the level of self-control and prevalence of certain coping strategies in patients with lesions of the right and left cerebral hemispheres after acute ischemic stroke. Materials and methods: The study included 60 patients with a diagnosis of ischemic stroke. Depending on the location of the stroke, patients were divided into two groups: Group 1 - 30 patients with lesions of the right hemisphere, Group 2 - 30 patients with lesions of the left hemisphere. The study was conducted on the 7th day of treatment and included: assessment of the cognitive status according to the Montreal scale (with additional scales for assessing the functions of the right hemisphere); assessment of the level of distress, depression, anxiety and somatization using the Four DimensionalSymptomQuestionnaire; assessment of mental and physical asthenia according to the MFI-20 scale, level of self-control using the Rotter'sLocus of Control Scale and coping strategies modality using E. Heim coping questionnaire. Results: The study established the prevalence of depression, a tendency towards non-adaptive coping strategies, ideational praxis related disorders understanding of metaphors and low level of self-control in relation to health in patients with lesions of the right hemisphere. Patients with ischemic stroke localized in the left hemisphere are characterized by a high level of mental asthenia, a choice of adaptive and relatively adaptive coping strategies, and a low level of self-control in respect to interpersonal relationships. Conclusions: The results of the study show that in the acute period of stroke there are qualitative and quantitative differences in neuropsychiatric symptoms of patients with lesions of the right and left cerebral hemispheres. The predominance of depression, cognitive impairments, and non-adaptive coping strategies in patients with lesions of the right hemisphere even with minimal or moderate motor deficits justifies early examination of the patient's behavioral, neuropsychiatric, and cognitive syndromes. The results of the study indicate the need to develop individual psychological rehabilitation programs for patients with lesions of the right and left cerebral hemispheres during the acute period of stroke.

show abstract

“…В наблюдаемой нами группе большинство пациентов ранее перенесли инсульт, после которого часто наблюдается прогрессирование КН, что может быть связано как с появлением новых сосудистых поражений, так и с развитием нейродегенеративного процесса [23]. Следует отметить, что основу ведения пациентов с ХЦВЗ, перенесших инсульт или транзиторную ишемическую атаку, составляют нелекарственные методы профилактики инсульта и КН (отказ от курения, злоупотребления алкоголем, регулярная физическая и умственная активность), а также достижение нормального уровня артериального давления на фоне антигипертензивной терапии и, по показаниям, прием антитромботических средств и статинов [2,4,11].…”

Section: к а з а т е л и н е й р о п с и х о л о г и ч е с к о г о о unclassified

Clinical experience with piribedil in chronic cerebrovascular disease with cognitive impairment

Мороз

Захарычева

Аntonyuk

2019

RJTAO

View full text Add to dashboard Cite

1 Владивостокский филиал ФГБНУ «Дальневосточный научный центр физиологии и патологии дыхания» -Научноисследовательский институт медицинской климатологии и восстановительного лечения, Владивосток, Россия; 2 ФГБОУ ВО «Дальневосточный государственный медицинский университет» Минздрава России, Хабаровск, Россия 1 690105, Владивосток, Русская, 73Г; 2 680000, Хабаровск, ул. Муравьева-Амурского, 35 Цель исследования -оценка влияния пирибедила на когнитивные функции у пожилых пациентов с хроническим цереброваскулярным заболеванием (ХЦВЗ) и когнитивными нарушениями (КН). Пациенты и методы. Обследовано 67 пациентов с ХЦВЗ и КН в возрасте 60-75 лет. В контрольную группу включено 32 пациента, которые получали базовую терапию (антигипертензивные и, по показаниям, гиполипидемические и антитробмотические средства). Основную группу составили 35 пациентов, дополнительно принимавших пирибедил по 50 мг вечером после еды в течение 3 мес. Нейропсихологическое обследование проводилось до и после курса лечения. Результаты и обсуждение. Через 3 мес только в группе пациентов, получавших пирибедил, отмечено достоверное улучшение нейропсихологических показателей (p<0,05-0,001). Статистически значимые различия выявлены по показателям кратковременной памяти (). Отмечены хорошая переносимость препарата и отсутствие нежелательных явлений, лекарственных взаимодействий. Заключение. При ХЦВЗ и КН прием пирибедила по 50 мг 1 раз в сутки в течение 3 мес способен улучшить когнитивные функции у пожилых пациентов, что указывает на целесообразность его использования в комбинированной терапии с основными (антигипертензивными, гиполипидемическими, антитромботическими) лекарственными средствами. Ключевые слова: хроническая недостаточность мозгового кровообращения III стадии; сосудистые когнитивные нарушения; пирибедил; когнитивные функции. Контакты: Елена Владимировна Мороз; lena-mor@mail.ru Для ссылки: Мороз ЕВ, Захарычева ТА, Антонюк МВ. Клинический опыт применения пирибедила при хроническом цереброваскулярном заболевании с когнитивными нарушениями. Неврология, нейропсихиатрия, психосоматика.

show abstract

Post-stroke cognitive impairment (results of a 5-year follow-up)

Cited by 25 publications

References 22 publications

Prevalence and Associated Factors of Cognitive Impairment Among Stroke Survivors at Comprehensive Specialized Hospitals in Northwest Ethiopia: Multi-Centered Cross-Sectional Study

Prevalence and Associated Factors of Cognitive Impairment Among Stroke Survivors at Comprehensive Specialized Hospitals in Northwest Ethiopia: Multi-Centered Cross-Sectional Study

Diagnostic of psychoemotional and cognitive impairments in acute ischemic stroke

Clinical experience with piribedil in chronic cerebrovascular disease with cognitive impairment

Contact Info

Product

Resources

About